MedPath

Optimising mealtime insulin bolusing algorithms for dietary fat to improve glycaemic control in adults with type 1 diabetes.

Not Applicable
Completed
Conditions
Type 1 Diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12617000828325
Lead Sponsor
The University of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

Aged 18-70y, T1D diagnosed for less than or equal to 1 year, CSII for less than or equal to 3 months, HbA1c for less than or equal to 8.5% (69 mmol/mol), reliably performing self-monitoring of blood glucose at least four times daily and fluency in English.

Exclusion Criteria

Concurrent medical issues including coeliac disease and gastroparesis, food allergies, intolerances or eating disorders or use of other medication that may influence blood glucose levels, pregnancy or lactation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in 5hr iAUCglucose (Part 1)[The 5hr iAUCglucose will be calculated from capillary blood glucose level measurements taken at 15-30 minute intervals for 5 hrs (0, 15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 270, 300 minutes).];Mean insulin dose (Part 2)[Insulin dose administered for the study session is recorded at the time the insulin dose is given (t = 0)];Mean insulin dose dual-wave split (Part 2)[Insulin dose dual-wave split administered for the study session is recorded at the time the insulin dose is given (t = 0)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath